Chemical Engineering · Pre-PharmD · Tennessee Tech

Jeffrey
Snyder

Driven by the intersection of chemistry, computation, and medicine — applying biochemical & engineering fundamentals to real-world pharmaceutical and clinical challenges.

PROSPECTIVE ACS 2027
// current research focus
Ionic Pharmaceuticals
Parkinson's Disease · Transdermal Delivery
Molecular Docking Quantum Mechanics Pharmacophore MOE · G16

A scientist at heart, a problem solver by nature

I'm Jeffrey Snyder, a Chemical Engineering student at Tennessee Technological University with a deep interest in pharmaceutical science, molecular modeling, and drug discovery.

My research spans computational chemistry and biophysical modeling — from quantum mechanical analysis of receptor-ligand binding to electrokinetic-hydrodynamic modeling of kidney filtration. I approach every problem with an interdisciplinary lens, integrating theory, computation, and hands-on lab work.

My clinical exposure comes from internship experience at Maury Regional Health, where I worked across both pharmacy and plant operations — giving me a rare combination of pharmaceutical and engineering fluency in a hospital environment.

3.5 College GPA
3 Research projects
50K+ Users reached (NavaLabs)
Expertise

Core competencies

A toolkit built across coursework, clinical internships, and research.

⚗️

Chemical Engineering

Foundational training in thermodynamics, transport phenomena, reaction kinetics, and calculus-based engineering methods.

Thermodynamics Transport Phenomena Reaction Kinetics General Chemistry Calculus
💊

Pharmaceutical Sciences

Hands-on pharmacy experience combined with academic knowledge of molecular modeling, pharmacophore analysis, and basic pharmacology.

Molecular Modeling Pharmacophore Basic Pharmacology Drug Interactions Rx Verification
🔬

Laboratory Techniques

Experience with standard general chemistry lab procedures, analytical techniques, and maintaining accuracy in high-paced clinical and academic environments.

Titration Spectroscopy Wet Lab Methods Lab Safety Transdermal Permeation
💻

Computational Skills

Applied programming for scientific modeling, data pipelines, and software development — including four years of active project leadership.

Python Java JavaScript Excel MOE 2024 Gaussian 16

Where I've worked

Jul 2025 – Aug 2025  ·  Dec 2025 – Jan 2026

Pharmacy Intern / Shadow

Maury Regional Health — Marshall Medical Center · Lewisburg, TN

Assisted pharmacists in reviewing and filling prescriptions, preparing medications, and verifying patient information in a high-paced clinical environment. Supported medication history management, observed drug interaction protocols, and shadowed patient consultations to understand clinical reasoning behind drug therapies. Increased back-end workflow efficiency during peak hours.

Jun 2025 – Jul 2025

Plant Operations Intern (HSW-1)

Maury Regional Health — Marshall Medical Center · Lewisburg, TN

Supported hospital infrastructure through hands-on electrical and HVAC work. Performed critical evaluations of generator code, load balancing, and backup power testing to meet compliance standards. Completed sheet metal fabrication and installation, ceiling space inspections, and breaker/wiring audits per Joint Commission regulations.

Apr 2020 – Jun 2024

Founder & Technical Lead

NavaLabs · Self-Employed / Remote · Chapel Hill, TN

Founded and led a remote game development studio delivering immersive virtual experiences. Grew to 50,000+ unique users and 100,000+ sessions. Managed team recruitment, onboarding, and Java/Python development pipelines. Directed creative vision across game design, feature scoping, QA coordination, and community engagement. Fostered hands-on leadership and practical design thinking.

Academic research

Three ongoing and completed projects spanning computational chemistry, biophysical modeling, and transdermal drug delivery.

01

Molecular Docking, Pharmacophore Modeling, and Quantum Mechanical Analysis of Methylxanthines Binding to the Adenosine Receptor

Advisor: Derek Cashman, Ph.D.  ·  2025–2026  ·  Tools: MOE 2024, Gaussian 16

A computational investigation into how caffeine, theobromine, and theophylline interact with the adenosine receptor. Ligands were docked into the receptor active site generating five low-energy conformations ranked by binding Gibbs free energy. Quantum mechanical calculations at the B3LYP/6-31G level of theory evaluated electronic structure via HOMO and LUMO orbital mapping. Noncovalent contributions — London dispersion and electrostatic interactions — were analyzed via Coulomb's law to explain differences in receptor affinity across methylxanthines.

🏆 Won Creative Research & Inquiry Day 2025 Symposium — Only ChE Undergraduate
Cashman poster preview
👆 Click to view poster
Computational
02

Understanding Kidney Filtration via Electrokinetic-Hydrodynamic Concepts — A Foundry Guided Study

Advisor: Pedro E. Arce, PhD, FRSC  ·  Framework: Renaissance Foundry Model (RFM)

A biophysical modeling study of glomerular filtration in the human kidney using electrokinetic-hydrodynamics (EKHD). The research develops a mathematical model capturing how fluid pressure and electrically driven solute transport operate across the filtration membrane in Bowman's capsule. By combining EKHD with the Renaissance Foundry Model, electrophoretic and electroosmotic transport mechanisms within the glomerulus are quantitatively described and analyzed.

Arce poster preview
👆 Click to view poster
Biophysical
03

Computational Analysis of Parkinson's Disease Compounds for Transdermal Delivery — Structure-Property Relationships

Advisor: Dr. Cojocaru  ·  2026–2027  ·  Wet Lab + Computational

Building on the Cojocaru research group's promising transdermal delivery results using static permeation systems, this project applies computational chemistry to predict key physicochemical properties and reactivity of synthesized Parkinson's disease compounds. Work involves modeling structure-property relationships, evaluating molecular stability, ion pairing, and electronic distribution, and identifying structural trends that explain differences in transdermal behavior. The goal is to bridge wet lab permeation data with theoretical molecular insight to guide future compound optimization. Culminates in a formal 10–15 page report in ACS documentation style, supported by peer-reviewed literature.

🎤 Prospective National ACS Presentation · 2027
Drug Delivery
Let's Connect

Get in touch

Open to research collaborations, academic conversations, and professional opportunities.